FIELD: chemistry.
SUBSTANCE: invention relates to novel cycloalkylmethylamine derivatives of formula (II) and (IV), having monoamine transporter inhibiting activity. In formula (II): 
, n equals 1; SP denotes a spacer - C1-6alkylene-O-; X denotes O or NH; R2 denotes hydrogen or C1-6alkyl; R3 denotes hydrogen, -COO-C1-6alkyl or -COO-C1-6alkylene phenyl; R4 denotes hydrogen; R5 denotes hydrogen, halogen, C1-6alkoxy; and R6 denotes C1-6alkyl. In formula (IV): 
, n equals 1; SP denotes a spacer selected from a group consisting of C1-6alkylene or a single bond; X denotes O or NH; R2 denotes C1-6alkyl; R4 denotes hydrogen or phenyl C1-6alkyl; R5 denotes halogen, hydroxy group or C1-6alkoxy; R6 denotes C1-6alkyl; R7 denotes hydrogen, halogen, hydroxy group or C1-6alkoxy.
EFFECT: high effectiveness when treating or preventing obesity or depression.
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS, SYNTHESIS AND METHODS OF APPLYING ARYLPIPERAZINE DERIVATIVES | 2010 |
|
RU2506262C2 |
| COMPOSITIONS, SYNTHESIS AND METHODS OF USING INDANONE BASED CHOLINESTERASE INHIBITORS | 2007 |
|
RU2478619C2 |
| COMPOSITIONS, SYNTHESIS AND METHOD FOR USING ATYPICAL ANTIPSYCHOTIC DRUGS OF QUINOLINE | 2008 |
|
RU2497819C2 |
| COMPOSITIONS, SYNTHESIS AND METHODS FOR APPLICATION OF PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES | 2012 |
|
RU2642074C2 |
| TREATMENT OR PREVENTION OF RESTLESS LEGS SYNDROME WITH USING PROMEDICINES OF GABA ANALOGUES | 2004 |
|
RU2377234C2 |
| PROTEIN TYROSINE KINASE RECEPTOR INHIBITOR COMPOSITIONS | 2009 |
|
RU2586212C2 |
| TREATMENT AND PREVENTION OF RESTLESS LEG SYNDROME WITH USING GABA ANALOGUE PRODRUGS | 2004 |
|
RU2458049C2 |
| LEVODOP PRODRUGS, BASED ON THEM COMPOSITIONS AND THEIR APPLICATION | 2005 |
|
RU2365580C2 |
| COMPOUNDS INHIBITING (BLOCKING) BITTER TASTE, METHODS FOR USE AND PRODUCTION THEREOF | 2008 |
|
RU2522456C2 |
| COMPOUNDS AND METHODS FOR TREATING LEUKEMIA | 2013 |
|
RU2672553C2 |
